Test paper for detecting human chorionic gonadotropin
By designing the structure of the detector main body and secondary detection paper in the human chorionic gonadotropin detection test paper, the problems of poor sealing performance and single detection method are solved, and higher detection safety and accuracy are achieved, and multiple and Multiple groups of detection.
Patent Information
- Application Number
- CN202420879875.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-26
- Publication Date
- 2025-01-03
- Estimated Expiration
- 2034-04-26
AI Technical Summary
The existing human chorionic gonadotropin detection test strips have insufficient sealing performance and are easily contaminated. The detection method is single, multiple sets of testing cannot be performed simultaneously, and the detection accuracy is insufficient.
A structure including a detector main body, a main detection paper and a sub-detection paper are designed. The end of the main detection paper is equipped with an integral liquid conductor sheet and a liquid drop port. The sub-detection paper is a foldable structure, and the first and The second display port is sealed by sealing the detection port, improving the multiple use and accuracy of detection.
The safety and accuracy of detection are enhanced, allowing multiple detections and improving the detection effect. Through sealing patches and foldable secondary detection paper structures, pollution and sputtering are prevented, and multiple sets of simultaneous detection capabilities of detection are improved.
Smart Images
Figure CN222299637U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the field of human chorionic gonadotropin detection test strips, in particular to a human chorionic gonadotropin detection test strip. Background Art
[0002] Human chorionic gonadotropin test strips are used to detect human chorionic gonadotropin. Human chorionic gonadotropin (HCG) is a glycoprotein secreted by the trophoblast cells of the placenta, composed of α and β dimer glycoproteins; it can be excreted into the urine through the blood circulation of pregnant women. When the pregnancy is 1-2.5 weeks, the HCG level in serum and urine can rise rapidly. Commonly used detection methods include latex aggregation inhibition test and hemagglutination inhibition test;
[0003] For example, the authorized patent with publication number CN207440111U (human chorionic gonadotropin test strip): it includes a strip-shaped body, a detection area and a control line are provided on the strip-shaped body, a storage bag is provided at the lower part of the strip-shaped body, the storage bag is fixed to the lower end of the strip-shaped body by a rectangular frame, the rectangular frame is located below the control line, an opening is provided on the lower side of the storage bag, and the opening is sealed by an easy-pull baffle. The rectangular frame is made of thin iron wire, cardboard or rubber. The easy-pull baffle is connected to the storage bag by crimping. The storage bag is a plastic bag or has a plastic film on the inside. The utility model is provided with a storage bag at the lower part of the strip-shaped body for storing urine to be tested, and the phenomenon of the test strip being invalid and wasted due to the urine to be tested exceeding the control line will not occur;
[0004] The human chorionic gonadotropin test strip of the prior art has poor sealing performance and is easily contaminated after being disassembled. The test port cannot be sealed, and the test method is single and multiple groups cannot be tested simultaneously, resulting in insufficient test accuracy. Utility Model Content
[0005] The purpose of the utility model is to provide a human chorionic gonadotropin test strip to solve the problems that the human chorionic gonadotropin test strip proposed in the above-mentioned background technology has insufficient sealing performance, is easily contaminated after being disassembled, cannot seal the detection port, has a single detection method, cannot perform multiple groups of simultaneous detection, and has insufficient detection accuracy.
[0006] To achieve the above-mentioned purpose, the utility model provides the following technical solutions: a human chorionic gonadotropin test strip, comprising a detector body, a main test strip is arranged inside the detector body, an integral liquid guide sheet is arranged at the end of the main test strip, a drip port is arranged at the top of the liquid guide sheet, integrated auxiliary test strips are arranged on both sides of the main test strip, and a first display port and a second display port are respectively arranged at the middle of the top of the auxiliary test strip and the main test strip.
[0007] In a further embodiment, a detection port is provided in the middle of the top end of the detector body, and a sealing patch is sealed on the detection port.
[0008] In a further embodiment, the auxiliary detection paper is configured as a foldable structure, and a liquid conducting core is provided inside both the auxiliary detection paper and the main detection paper.
[0009] In a further embodiment, a detection layer is disposed inside the first display port and the second display port, and a first protection groove and a second protection groove are disposed outside the first display port and the second display port, respectively.
[0010] In a further embodiment, an anti-sputtering groove is provided on the outer side of the dripping port.
[0011] In a further embodiment, the dripping port and the second display port are both located at the detection port and are arranged directly opposite to the detection port.
[0012] Compared with the prior art, the beneficial effects of the utility model are:
[0013] 1. The utility model is provided with a detector body, a detection port is provided on the front of the detector body, and a removable sealing patch is provided on the detection port, so that the second display port and the drip port can be sealed to prevent infection, thereby increasing safety.
[0014] 2. Auxiliary detection papers are arranged on both sides of the main detection paper of the utility model. A first display port is arranged on the auxiliary detection paper. Multiple detections can be performed in conjunction with the main detection paper, so that the detection effect can be improved and the detection can be made more accurate. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 This is a schematic structural diagram of a human chorionic gonadotropin test strip of the utility model;
[0016] Figure 2 It is a top view of the detector body of the utility model in the unfolded state of the auxiliary detection paper;
[0017] Figure 3 It is a top view of the detector body of the utility model in the state where the auxiliary detection paper is folded;
[0018] Figure 4 It is a top view of the main detection paper and the auxiliary detection paper of the utility model.
[0019] In the figure: 1. auxiliary detection paper; 2. first protective groove; 3. first display port; 4. detector body; 5. main detection paper; 6. anti-sputtering groove; 7. drip port; 8. liquid guide plate; 9. sealing patch; 10. second protective groove; 11. second display port. DETAILED DESCRIPTION
[0020] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments.
[0021] See also Figure 1-4 The utility model provides an embodiment: a human chorionic gonadotropin test paper, comprising a detector body 4, a main test paper 5 is arranged inside the detector body 4, an integral liquid guide sheet 8 is arranged at the end of the main test paper 5, a dripping port 7 is arranged at the top of the liquid guide sheet 8, and an integral auxiliary test paper 1 is arranged on both sides of the main test paper 5, and a first display port 3 and a second display port 11 are respectively arranged at the middle of the top of the auxiliary test paper 1 and the main test paper 5; human chorionic gonadotropin is detected by the main test paper 5, the liquid guide sheet 8 is used to guide the dripped urine into the detection layer, the dripping port 7 is used to facilitate the dripping of urine, and the auxiliary test paper 1 is used to assist the detection of urine, multiple detections can be performed to improve the detection effect, and the data are displayed through the first display port 3 and the second display port 11.
[0022] A detection port is provided in the middle of the top of the detector body 4 , and a sealing patch 9 is sealed on the detection port, so that the detection port can be sealed by the sealing patch 9 .
[0023] The auxiliary detection paper 1 is configured as a foldable structure, and liquid guiding cores are provided inside the auxiliary detection paper 1 and the main detection paper 5 to facilitate liquid guiding.
[0024] A detection layer is provided in the first display port 3 and the second display port 11, and a first protective groove 2 and a second protective groove 10 are provided on the outer sides of the first display port 3 and the second display port 11, respectively, and the first protective groove 2 and the second protective groove 10 are used to protect the first display port 3 and the second display port 11, respectively; an anti-splashing groove 6 is provided on the outer side of the drip port 7, and the anti-splashing groove 6 can be used to protect the outer side of the drip port 7 from splashing; the drip port 7 and the second display port 11 are both located at the detection port and are arranged directly opposite to the detection port.
[0025] Working principle: When in use, the detection port is sealed by the sealing patch 9, the sealing patch 9 is opened, and the two auxiliary detection papers 1 are unfolded, urine is added to the drip port 7, and the urine is protected from splashing through the anti-splashing groove 6. The urine is introduced into the main detection paper 5 through the liquid guide sheet 8, and then introduced into the auxiliary detection paper 1 through the main detection paper 5, and displayed through the first display port 3 and the second display port 11 on the auxiliary detection paper 1 and the main detection paper 5. The first display port 3 and the second display port 11 can be protected from damage through the first protection groove 2 and the second protection groove 10 respectively.
[0026] It is obvious to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above, and that the present invention can be implemented in other specific forms without departing from the spirit or essential features of the present invention. Therefore, the embodiments should be regarded as exemplary and non-restrictive from any point of view, and the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention. Any reference numeral in a claim should not be regarded as limiting the claim to which it relates.
Claims
1. A human chorionic gonadotropin test strip, comprising a detector body (4), characterized in that: A main detection paper (5) is arranged inside the detector body (4); an integral liquid guide sheet (8) is arranged at the end of the main detection paper (5); a liquid drop port (7) is arranged at the top of the liquid guide sheet (8); integrated auxiliary detection papers (1) are arranged on both sides of the main detection paper (5); a first display port (3) and a second display port (11) are respectively arranged at the middle of the top of the auxiliary detection paper (1) and the main detection paper (5).
2. A human chorionic gonadotropin test strip according to claim 1, characterized in that: A detection port is provided in the middle of the top end of the detector body (4), and a sealing patch (9) is sealed on the detection port.
3. A human chorionic gonadotropin test strip according to claim 1, characterized in that: The auxiliary detection paper (1) is configured as a foldable structure, and a liquid conducting core is provided inside both the auxiliary detection paper (1) and the main detection paper (5).
4. A human chorionic gonadotropin test strip according to claim 1, characterized in that: A detection layer is provided inside the first display port (3) and the second display port (11), and a first protection groove (2) and a second protection groove (10) are provided outside the first display port (3) and the second display port (11), respectively.
5. The human chorionic gonadotropin test strip according to claim 1, characterized in that: An anti-sputtering groove (6) is provided on the outer side of the liquid dripping port (7).
6. A human chorionic gonadotropin test strip according to claim 1, characterized in that: The liquid dripping port (7) and the second display port (11) are both located at the detection port and are arranged directly opposite to the detection port.